Search research articles
Contact Us
Filters
Showing results (151-160 of 173) with videos related to
Page
of 18
Sort By:
Cancer Letters
|
January 27, 2018
Nogo-B receptor increases the resistance of estrogen receptor positive breast cancer to paclitaxel
Ying Jin, Wenquan Hu, Tong Liu, et al.
The Oncologist
|
April 26, 2020
Current Status and Factors Influencing Surgical Options for Breast Cancer in China: A Nationwide Cross-Sectional Survey of 110 Hospitals
Benlong Yang, Guosheng Ren, Erwei Song, et al.
JMIR Public Health and Surveillance
|
December 7, 2023
Safety of COVID-19 Vaccination in Patients With Breast Cancer: Cross-Sectional Study in China
Shaohua Zhang, Jianbin Li, Ruonan Xu, et al.
Health and Quality of Life Outcomes
|
March 25, 2016
Health-related quality of life of postmenopausal Chinese women with hormone receptor-positive early breast cancer during treatment with adjuvant aromatase inhibitors: a prospective, multicenter, non-interventional study
Ayong Cao, Jin Zhang, Xiaoan Liu, et al.
Molecular Genetics & Genomic Medicine
|
April 11, 2019
Prevalence of BRCA1 and BRCA2 gene mutations in Chinese patients with high-risk breast cancer
Xiaozhen Wang, Haimeng Liu, Amina Maimaitiaili, et al.
Bioactive Materials
|
June 22, 2026
An AI-integrated organoid platform enables high-throughput functional evaluation of bioactive metal ions
Yi Shao, Yongfeng Wang, Yan Wang, et al.
Oncogene
|
October 19, 2022
STAT5 confers lactogenic properties in breast tumorigenesis and restricts metastatic potential
Meng Lin, Amy T Ku, Jie Dong, et al.
Frontiers in Oncology
|
May 17, 2021
Establishment and Verification of a Predictive Model for Node Pathological Complete Response After Neoadjuvant Chemotherapy for Initial Node Positive Early Breast Cancer
Jiujun Zhu, Dechuang Jiao, Min Yan, et al.
Therapeutic Advances in Medical Oncology
|
March 9, 2023
Efficacy analysis of neoadjuvant chemotherapy with or without anthracyclines in female patients with HER2-positive breast cancer in China: a nationwide, multicenter, 10-year retrospective study (CSBrS-012)
Heyan Chen, Amina Maimaitiaili, Zhenzhen Liu, et al.
Iscience
|
July 18, 2025
Application of sentinel lymph nodes biopsy tracers for breast cancer after neoadjuvant chemotherapy in China: A multicenter, real-world study
Fengjiang Qu, Tinghan Jiang, Zhenzhen Liu, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 173) with videos related to
Sort By:
Page
of 18
Cancer Letters
|
January 27, 2018
Nogo-B receptor increases the resistance of estrogen receptor positive breast cancer to paclitaxel
Ying Jin, Wenquan Hu, Tong Liu, et al.
The Oncologist
|
April 26, 2020
Current Status and Factors Influencing Surgical Options for Breast Cancer in China: A Nationwide Cross-Sectional Survey of 110 Hospitals
Benlong Yang, Guosheng Ren, Erwei Song, et al.
JMIR Public Health and Surveillance
|
December 7, 2023
Safety of COVID-19 Vaccination in Patients With Breast Cancer: Cross-Sectional Study in China
Shaohua Zhang, Jianbin Li, Ruonan Xu, et al.
Health and Quality of Life Outcomes
|
March 25, 2016
Health-related quality of life of postmenopausal Chinese women with hormone receptor-positive early breast cancer during treatment with adjuvant aromatase inhibitors: a prospective, multicenter, non-interventional study
Ayong Cao, Jin Zhang, Xiaoan Liu, et al.
Molecular Genetics & Genomic Medicine
|
April 11, 2019
Prevalence of BRCA1 and BRCA2 gene mutations in Chinese patients with high-risk breast cancer
Xiaozhen Wang, Haimeng Liu, Amina Maimaitiaili, et al.
Bioactive Materials
|
June 22, 2026
An AI-integrated organoid platform enables high-throughput functional evaluation of bioactive metal ions
Yi Shao, Yongfeng Wang, Yan Wang, et al.
Oncogene
|
October 19, 2022
STAT5 confers lactogenic properties in breast tumorigenesis and restricts metastatic potential
Meng Lin, Amy T Ku, Jie Dong, et al.
Frontiers in Oncology
|
May 17, 2021
Establishment and Verification of a Predictive Model for Node Pathological Complete Response After Neoadjuvant Chemotherapy for Initial Node Positive Early Breast Cancer
Jiujun Zhu, Dechuang Jiao, Min Yan, et al.
Therapeutic Advances in Medical Oncology
|
March 9, 2023
Efficacy analysis of neoadjuvant chemotherapy with or without anthracyclines in female patients with HER2-positive breast cancer in China: a nationwide, multicenter, 10-year retrospective study (CSBrS-012)
Heyan Chen, Amina Maimaitiaili, Zhenzhen Liu, et al.
Iscience
|
July 18, 2025
Application of sentinel lymph nodes biopsy tracers for breast cancer after neoadjuvant chemotherapy in China: A multicenter, real-world study
Fengjiang Qu, Tinghan Jiang, Zhenzhen Liu, et al.
Page
of 18